Your browser doesn't support javascript.
loading
MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang, Lin; Song, Guanhua; Tan, Weiwei; Qi, Mei; Zhang, Lili; Chan, Jonathan; Yu, Jindan; Han, Jinxiang; Han, Bo.
Affiliation
  • Wang L; Research Center for Medicinal Biotechnology, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Shandong Academy of Medicinal Sciences, Jinan, China.
  • Song G; Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, China.
  • Tan W; Department of Pathology, Shandong University Medical School, Jinan, China.
  • Qi M; Department of Pathology, Shandong University Medical School, Jinan, China.
  • Zhang L; Department of Pathology, Shandong University Medical School, Jinan, China.
  • Chan J; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Yu J; Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Han J; Research Center for Medicinal Biotechnology, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Shandong Academy of Medicinal Sciences, Jinan, China.
  • Han B; Department of Pathology, Shandong University Medical School, Jinan, China.
Oncotarget ; 6(34): 35978-90, 2015 Nov 03.
Article in En | MEDLINE | ID: mdl-26451614

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / MicroRNAs / Epithelial-Mesenchymal Transition Limits: Animals / Humans / Male / Middle aged Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: China Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / MicroRNAs / Epithelial-Mesenchymal Transition Limits: Animals / Humans / Male / Middle aged Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: China Country of publication: Estados Unidos